Provost honours FMHS profs

McGill announces 2025 cohort of Distinguished James McGill Professors, James McGill Professors and William Dawson Scholars  Provost and Vice-President (Academic) Christopher Manfredi has...
May 2, 2025

Immunotherapy before surgery shows promise for esophageal cancer

New study by researchers at The Institute finds improved survival and potential for personalized treatment A new study by researchers at The Institute...
May 1, 2025

How blood vessels adapt to high blood pressure: A new discovery

Researchers uncover how endothelial cells sense and respond to loss of function, offering insights into vascular health and potential new treatments for hypertension...
May 1, 2025

Teaming up to improve breast cancer treatments through a new approach

Treating without surgery: the ultimate goal that radiation oncologists at the MUHC and HMR hope to achieve A patient diagnosed with grade 1...
May 1, 2025

Rheumatology outreach in Abitibi

Welcome to our series, McGill in Quebec: Together for better health, which celebrates the contributions of Faculty of Medicine and Health Sciences members...
May 1, 2025

Landmark collaboration  probes the foundations of consciousness 

A major international study, the results of which were published today in Nature marks a historic milestone in the scientific investigation of consciousness....
May 1, 2025

Drugs targeting ‘zombie cells’ show promise for treating chronic back pain

Research in mice identifies drug combination that can slow or even reverse spine damage In a preclinical study led by McGill University researchers, two drugs...
April 28, 2025

First patient in Canada receives mRNA-based bladder cancer treatment in clinical trial at the MUHC 

The investigational therapy combines mRNA technology with immunotherapy to train the immune system to target cancer cells after surgery In a new milestone...
April 16, 2025

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Three members of The Institute are among recipients of D2R funding to support their groundbreaking research on RNA-based therapies for cancer and rare...
April 16, 2025

D2R: A growing community with a shared vision

Earlier this month, over 150 researchers from across McGill and partner institutions came together at Le Centre Sheraton for the inaugural DNA to...
April 11, 2025

Inaugural Research Canada Innovates event at The Institute a resounding success

Sold-out event united health researchers and innovators to shape the future of healthcare On March 24, 2025, The Institute proudly partnered with Research...
April 11, 2025

What links cannabis use and psychosis? Researchers point to the brain’s dopamine system

‘Our findings could help doctors and mental health professionals better educate patients about the potential risks of frequent cannabis use’  A McGill University-led...
April 11, 2025

Epinephrine could reduce hospitalizations in pediatric intensive care after a severe allergic reaction

Research confirms the use of epinephrine before arrival at the hospital significantly reduces intensive care admissions for anaphylactic reactions During a severe allergic...
April 11, 2025

McGill TB experts publish a prestigious Lancet seminar

Commissioned work underscores the role of tuberculosis (TB) as a leading cause of death globally, stressing the importance of early diagnosis, comprehensive care,...
April 11, 2025